Psychedelic renaissance: revitalized potential therapies for psychiatric disorders
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psychedelic renaissance: revitalized potential therapies for psychiatric disorders
Authors
Keywords
-
Journal
DRUG DISCOVERY TODAY
Volume -, Issue -, Pages 103818
Publisher
Elsevier BV
Online
2023-11-03
DOI
10.1016/j.drudis.2023.103818
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape
- (2023) Sarah McNamee et al. JAMA Psychiatry
- Single-Dose Psilocybin Treatment for Major Depressive Disorder
- (2023) Charles L. Raison et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Psychedelics
- (2022) Benjamin Kelmendi et al. CURRENT BIOLOGY
- Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
- (2022) Felix Müller et al. PSYCHOPHARMACOLOGY
- Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder
- (2022) Deepak Cyril D’Souza et al. NEUROPSYCHOPHARMACOLOGY
- Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
- (2022) Friederike Holze et al. BIOLOGICAL PSYCHIATRY
- Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
- (2022) Joost J Breeksema et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neural basis of psychedelic action
- (2022) Alex C. Kwan et al. NATURE NEUROSCIENCE
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
- (2022) Guy M. Goodwin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preparing for the Bursting of the Psychedelic Hype Bubble
- (2022) David B. Yaden et al. JAMA Psychiatry
- Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002–2019
- (2022) Claire A. Walsh et al. Addictive Behaviors Reports
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
- (2021) Jennifer M. Mitchell et al. NATURE MEDICINE
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports
- (2021) Sandeep M. Nayak et al. PHARMACOPSYCHIATRY
- Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
- (2020) Franz X. Vollenweider et al. NATURE REVIEWS NEUROSCIENCE
- MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
- (2020) Philip E. Wolfson et al. Scientific Reports
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
- (2019) Michael C. Mithoefer et al. PSYCHOPHARMACOLOGY
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
- (2018) Matthew W. Johnson et al. NEUROPHARMACOLOGY
- Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans
- (2018) David J. Heal et al. NEUROPHARMACOLOGY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
- (2018) Alicia L. Danforth et al. PSYCHOPHARMACOLOGY
- A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
- (2018) Samuel T. Wilkinson et al. DRUG DISCOVERY TODAY
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
- (2017) R. L. Carhart-Harris et al. PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
- (2015) Paul E. Greenberg et al. JOURNAL OF CLINICAL PSYCHIATRY
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugs
- (2014) Dennis W. Choi et al. NEURON
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now